These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8870038)

  • 1. The new muscarinic M1-receptor agonist YM796 evokes yawning and increases oxytocin secretion from the posterior pituitary gland in rats.
    Fujikawa M; Yamada K; Nagashima M; Domae M; Furukawa T
    Pharmacol Biochem Behav; 1996 Sep; 55(1):55-60. PubMed ID: 8870038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of beta-adrenoceptors in regulation of the yawning induced by neuropeptides, oxytocin and alpha-melanocyte-stimulating hormone, in rats.
    Fujikawa M; Yamada K; Nagashima M; Furukawa T
    Pharmacol Biochem Behav; 1995 Mar; 50(3):339-43. PubMed ID: 7617671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological studies on novel muscarinic agonists, 1-oxa-8-azaspiro[4.5]decane derivatives, YM796 and YM954.
    Wanibuchi F; Konishi T; Harada M; Terai M; Hidaka K; Tamura T; Tsukamoto S; Usuda S
    Eur J Pharmacol; 1990 Oct; 187(3):479-86. PubMed ID: 1963596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of yawning responses to the dopamine receptor agonists B-HT 920 and SND 919 by pindolol in the rat.
    Yamada K; Matsumoto S; Nagashima M; Shirakawa K; Furukawa T
    J Neural Transm Gen Sect; 1990; 79(1-2):19-24. PubMed ID: 1967531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of a novel muscarinic partial agonist, YM796, in transfected cells expressing the m1 or m2 muscarinic receptor gene.
    Wei HB; Roeske WR; Lai J; Wanibuchi F; Hidaka K; Usuda S; Yamamura HI
    Life Sci; 1992; 50(5):355-63. PubMed ID: 1310135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of central beta-adrenoceptors in the regulation of yawning responses.
    Yamada K; Matsumoto S; Nagashima M; Kumagai M; Kimura H; Furukawa T
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):26-30. PubMed ID: 2571945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of catecholamine receptor activities in modulating the incidence of yawning in rats.
    Kimura H; Yamada K; Nagashima M; Furukawa T
    Pharmacol Biochem Behav; 1996 Apr; 53(4):1017-21. PubMed ID: 8801573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of (-)-S-2,8-dimethyl-3-methylene-1-oxa-8-azaspiro[4,5]decane L-tartrate monohydrate (YM796), a novel muscarinic agonist, on disturbance of passive avoidance learning behavior in drug-treated and senescence-accelerated mice.
    Suzuki M; Yamaguchi T; Ozawa Y; Ohyama M; Yamamoto M
    J Pharmacol Exp Ther; 1995 Nov; 275(2):728-36. PubMed ID: 7473160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a novel muscarinic receptor agonist, YM796: comparison with cholinesterase inhibitors in in vivo pharmacological studies.
    Wanibuchi F; Nishida T; Yamashita H; Hidaka K; Koshiya K; Tsukamoto S; Usuda S
    Eur J Pharmacol; 1994 Nov; 265(3):151-8. PubMed ID: 7875230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation and desensitization of the muscarinic M1 and M2 receptors in transfected fibroblast B82 cells.
    Wei HB; Yamamura HI; Roeske WR
    Eur J Pharmacol; 1994 Aug; 268(3):381-91. PubMed ID: 7805762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clavulanic acid induces penile erection and yawning in male rats: comparison with apomorphine.
    Sanna F; Melis MR; Angioni L; Argiolas A
    Pharmacol Biochem Behav; 2013 Feb; 103(4):750-5. PubMed ID: 23234836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of adrenergic neuronal activity in the yawning induced by tacrine and NIK-247 in rats.
    Kimura H; Yamada K; Nagashima M; Matsumoto S; Ishii Y; Yoshida S; Fujii K; Furukawa T
    Pharmacol Biochem Behav; 1992 Dec; 43(4):985-91. PubMed ID: 1361995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxytocin increases nitric oxide production in the paraventricular nucleus of the hypothalamus of male rats: correlation with penile erection and yawning.
    Melis MR; Succu S; Iannucci U; Argiolas A
    Regul Pept; 1997 Mar; 69(2):105-11. PubMed ID: 9178353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penile erection and yawning induced by 5-HT1C receptor agonists in male rats: relationship with dopaminergic and oxytocinergic transmission.
    Stancampiano R; Melis MR; Argiolas A
    Eur J Pharmacol; 1994 Aug; 261(1-2):149-55. PubMed ID: 8001637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT1A receptor agonists prevent in rats the yawning and penile erections induced by direct dopamine agonists.
    Simon P; Guardiola B; Bizot-Espiard J; Schiavi P; Costentin J
    Psychopharmacology (Berl); 1992; 108(1-2):47-50. PubMed ID: 1357709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation by serotonergic inhibition of yawning induced by dopamine receptor agonists in rats.
    Matsumoto S; Yamada K; Nagashima M; Matsuo N; Shirakawa K; Furukawa T
    Pharmacol Biochem Behav; 1989 Mar; 32(3):815-8. PubMed ID: 2525786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that apomorphine induces penile erection and yawning by releasing oxytocin in the central nervous system.
    Melis MR; Argiolas A; Gessa GL
    Eur J Pharmacol; 1989 May; 164(3):565-70. PubMed ID: 2767126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. d(CH2)5Tyr(Me)-[Orn8]vasotocin, a potent oxytocin antagonist, antagonizes penile erection and yawning induced by oxytocin and apomorphine, but not by ACTH-(1-24).
    Argiolas A; Melis MR; Vargiu L; Gessa GL
    Eur J Pharmacol; 1987 Feb; 134(2):221-4. PubMed ID: 3032653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the muscarinic receptor subtype involved in the mediation of pilocarpine-induced purposeless chewing behaviour.
    Stewart BR; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1989; 97(2):228-34. PubMed ID: 2498932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the oxytocin and vasopressin responses to the 5-HT1A agonist and potential anxiolytic drug alnespirone (S-20499).
    Van de Kar LD; Levy AD; Li Q; Brownfield MS
    Pharmacol Biochem Behav; 1998 Jul; 60(3):677-83. PubMed ID: 9678651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.